Corporate news - Gerresheimer

Corporate news

New oxy-hybrid furnace reduces CO2e emissions by up to 40%Latest production technology and environmentally friendly cooling systemCapacity expansion…
Read more
Renowned expert succeeds Manfred BaumannOliver Burgel assumes global responsibility for newly established Gerresheimer Syringe Systems Business Unit …
Read more
Revenues +11.6%, Adjusted EBITDA +13.1%Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3%Q1…
Read more
Organic growth: revenue +2.9%, adjusted EBITDA +4.1%Destocking in vial business partially offset by strong growth in medical devicesGrowth strategy…
Read more
Exchange with Gerresheimer management at the Düsseldorf headquartersGerresheimer produces medical systems such as inhalers and auto-injectors in…
Read more
Innovative combination product of furosemide and on-body deviceReady-to-market device designed, developed and manufactured by GerresheimerPatented…
Read more
Complementary product portfolio and broad footprint of production sites in EuropeStrengthening the market position as a full-service provider for the…
Read more
Expansion of the site in the Republic of North Macedonia with a new production hall for glass syringesTotal investment volume of over EUR 100 millionA…
Read more
2.3 MWp rooftop photovoltaic system on production buildingGerresheimer increases share of green electricity in its energy supplyGoal for 2030: 100%…
Read more

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com